Mohammad Nawab

Prof. Mohammad Nawab

National Research Institute of Unani Medicine for Skin Disorders, Hyderabad, India
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2019 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
NANadeem Ahmad
Nadeem Ahmad
MNMohammad Nawab
Mohammad Nawab
MKM Husain Kazmi
M Husain Kazmi
Unani System of Medicine (USM) is being practised as traditional, alternative and complementary medicine in India and other countries. In this system of medicine, medicinal plants are extensively used in the treatment of various kind of diseases since time immemorial. Herbo-mineral origin drugs are the main components of Unani Pharmacopoeia. Jamun (Syzygium cumini Linn) is one of the medicinal plants used for therapeutic purposes in Dhayābīṭus Ḥārr (diabetes mellitus), Ishāl-e- Damwī (haemorrhagic diarrhoea), Is’haal-i-Safrāwī (bilious diarrhoea), Ḍu‘f al-Ishtihā’(loss of appetite), Zaḥīr (dysentery) and Qulā (oral ulcer). In recent past its fruits, seeds, leaves, stem bark and its secondary metabolites have shown medicinal properties in various experimental and clinical studies. In this review we have tried to explore its ethno-botanical uses and pharmacological actions described in classical literature and scientific publications based on experimental studies. It is found that this plant plays an important role in prevention and management of non-communicable diseases such as Dhayābīṭus Ḥārr (diabetes mellitus), Sarṭān (cancer), Niqris (gout), ischaemic heart disease etc. Several preclinical studies have revealed that it has Muḥallil-i- Awrām (anti-inflammatory), Muḥāfiẓ-i- Qalb (cardio protective), Dafi‘-i-Ḥummā (anti-pyretic) and Muqawwī-i-Jigar (hepatotonic) properties. It also possesses anti-diabetic potential activity and considered as a potent anti-diabetic plant. Keywords: Unani, Jamun, Syzygium, Antidiabetic, Anti-inflammatory, Hepatoprotective

1 February 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
QAQurratul Ain
Qurratul Ain
MNMohammad Nawab
Mohammad Nawab
TATasleem Ahmad
Tasleem Ahmad
MKMunawwar H. Kazmi
Munawwar H. Kazmi
MNMohammed Abdul Rasheed Naikodi
Mohammed Abdul Rasheed Naikodi

5 August 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
BIBhoraniya Abdullah Ismail
Bhoraniya Abdullah Ismail
MNMohammad Nawab
Mohammad Nawab
SFsyeda hajra fatima
syeda hajra fatima
AMAhmed Minhajuddin
Ahmed Minhajuddin
MNMohammed Abdul Rasheed Naikodi
Mohammed Abdul Rasheed Naikodi

3 October 2021 in Traditional and Integrative Medicine
Verified
Journal Article
Closed access
BIBhoraniya Abdullah Ismail
Bhoraniya Abdullah Ismail
SFSyeda Hajra Fatima
Syeda Hajra Fatima
MNMohammad Nawab
Mohammad Nawab
Bahaq is a commonly encountered clinical condition of the skin. It is characterized by the presence of hypopigmented or hyperpigmented or erythematous macule which appears on the neck, chest, shoulder and arms. In classical literature, bahaq and its subtype bahaq abyad and bahaq aswad have been described. In a recent development, these Unani terminologies (bahaq abyad and bahaq aswad) have been correlated with the terminologies used in modern medicine for similar clinical presentation by the competent authority in India. The equivalent terms assigned for bahaq abyad as pityriasis alba and bahaq aswad as pityriasis nigra do not seem to be suitable. They lead to misdiagnosis and treatment failure. In this article, we have reviewed evidences from the literature to have current understanding of the clinical conditions bahaq abyad and bahaq aswad. The literature review showed that these two dermatological clinical conditions have an individual identity. They differ from each other in terms of clinical presentation, demographic characteristics, pathogenesis and treatment. Moreover, we have presented one case report of bahaq abyad and bahaq aswad each to have an understanding of its demographic characteristics, risk factors, clinical features and clinical course of the disease. We have diagnosed these cases as per descriptions mentioned in the classical literature and tried to correlate to the equivalent terms representing a similar clinical presentation in modern medicine. After a review of evidence, we hypothesize the most suitable equivalent terms for the clinical conditions bahaq abyad and bahaq aswad as pityriasis versicolor instead of bahaq abyad as pityriasis alba and bahaq aswad as pityriasis nigra. This research article may guide the Unani physicians in clinical practice for proper diagnosis, therapeutic approach, drugs selection and treatment of bahaq and its subtypes.

24 August 2022 in Drug Metabolism and Personalized Therapy
Verified
Journal Article
Closed access
SNSaima Naseem
Saima Naseem
MNMohammad Nawab
Mohammad Nawab
SFsyeda hajra fatima
syeda hajra fatima
AMAhmed Minhajuddin
Ahmed Minhajuddin
AKAsif Ahmad Khan
Asif Ahmad Khan
Objectives: The recent trends of rising unresponsive cases of dermatophytosis to conventional therapies pose a challenge in clinical practice. Unani medicine offers effective treatment for dermatophytosis. This study aimed to evaluate the efficacy and safety of the Unani herbo-mineral preparations Qurs-e-Asfar (QA) and Rogan-e-Narjeel (RN) in dermatophytosis. Methods: This was a randomized, active-controlled and open-label clinical study. The participants diagnosed with dermatophytosis (n=78) randomized into treatment group (n=40) receiving oral QA (778 mg twice a day) and topical RN and control group (n=38) receiving oral Itraconazole (100 mg/day) and topical Terbinafine hydrochloride (1%) for 6 weeks. Results: We found post-treatment improvement in itching by 86.3% vs. 78% (treatment vs. control group), erythema by 96.4% vs. 94.3%, scaling by 93% vs. 92.2% and peripheral raised margins by 82.3% vs. 81%. Furthermore, this study showed that the differences in the mean Total Signs and Symptoms Score (TSSS) and positive KOH mount were clinically and statistically significant (p<0.05) in both the groups. On comparing inter group, the differences in mean TSSS (p=0.07) and positive KOH mount (p=0.717) were found statistically insignificant. Conclusions: This study concludes that the formulations QA and RN were effective and safe in the treatment of dermatophytosis.

29 September 2021 in Journal of Complementary and Integrative Medicine
Verified
Journal Article
Closed access
IQIfra Abdul Qaiyyum
Ifra Abdul Qaiyyum
MNMohammad Nawab
Mohammad Nawab
MKMunawwar Husain Kazmi
Munawwar Husain Kazmi
Objectives: Kalaf (Melasma) is an acquired facial hypermelanism. It has direct impact on patient’s quality of life and leads to development of various personality disorders. Lack of effective treatment and recurrences have drawn the attention of researcher to find alternative treatment. This study aimed to evaluate safety and efficacy of a topical Unani formulation in the management of melasma. Methods: We conducted a prospective randomized controlled clinical study on the participants diagnosed with melasma. The participants (n=72) randomized into test (n=36) and control (n=36) groups. Sixty participants (n=30 in each group) completed the duration of therapy. The participants of the test group were treated with a classical Unani formulation and control group with hydroquinone 4%. The primary end point was change in mean MASI score and secondary end point was improvement in quality of life after eight weeks of treatment. Results: The Unani formulation reduced 40.5% mean MASI score (17.31 ± 9.58 to 10.28 ± 5.92) in comparison to 32% reduction in mean MASI score (20.58 ± 9.49 to 13.92 ± 7.38) in the control group after eight weeks of treatment. When comparing with baseline the difference in MASI score was found statistically significant in both groups (p0.05). In addition, MQOL and DQLI also improved significantly in both groups. Conclusions: This study concluded that the Unani formulation and the control drug were equally effective and safer in the management of melasma.